The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...

The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

Today at the American College of Physicians (ACP) annual meeting, Internal Medicine Meeting 2025, in New Orleans, Annals of ...

Jim Cramer in a latest program on CNBC urged investors to start accepting the reality of the new economic system under ...

The General Directorate of Drugs, Food, and Health Products (Digemaps) issued a public warning about unapproved weight-loss ...

Authors discuss research on AI in the exam room, switching GLP1-RAs for better glucose and weight control, and ACP's best ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

CHARLIE Sadler had never felt so low in his life – weighing 34 stone and stuck in a painful cycle of comfort eating he saw no ...